Drug profile
Here's what the FDA CVM extract says about Glucosamine Hydrochloride, Sodium Chondroitin Sulfate, And Methylsulfonylmethane
The CVM extract lists 10 reports for Glucosamine Hydrochloride, Sodium Chondroitin Sulfate, And Methylsulfonylmethane, a lower-volume entry. Species, reactions, and outcomes are below.
- #2590 of 2,679
- by report volume (all drugs)
- 10
- adverse-event reports
- 30.0%
- death-coded share
- Dog
- most-reported species
Corpus placement
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Glucosamine Hydrochloride, Sodium Chondroitin Sulfate, And Methylsulfonylmethane ranks #2536 of 2679 by total reports (10). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).
- 149,624
- Milbemycin Oxime + Spinosad reports (#1)
- 97.8%
- Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
- #2536
- This drug, reports of 2679
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Signature read: 10 reports place Glucosamine Hydrochloride, Sodium Chondroitin Sulfate, And Methylsulfonylmethane in the lower third of FDA AER volume (#2590 of 2,679).
Active Ingredients
Administration Routes
Species Affected
Most Affected Breeds
Most Reported Reactions
Outcome Breakdown
Glucosamine Hydrochloride, Sodium Chondroitin Sulfate, And Methylsulfonylmethane: high death-coded share in the FDA AER row
Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.
Next steps with this data
- Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
- See how this report count compares across the full drug directory. All drugs
A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →